. Author manuscript; available in PMC: 2024 May 28.

Published in final edited form as: Sci Transl Med. 2023 Sep 6;15(712):eadh0380. doi: 10.1126/scitranslmed.adh0380

Table 1.

Clinical characteristics of patients with GCA aortitis or non-inflamed ascending aortic aneurysm.

	Non-inflamed ascending	Aortitis (n = 22)
	aortic aneurysm (n = 20)	Aortitis (n = 22)
Age (mean ± SD)	72.5 ± 6.5	74.0 ± 6.1
Male:Female	8:12	10:10
ESR (mean ± SD, mm/hr)	4.95 ± 9.2	6.3 ± 8.5
CRP (mean ± SD, mg/L )	0.79 ± 1.5	3.3 ± 3.7
Treatment
Prednisone	0 (0%)	1 (4.5%)
Prednisone dose (mg/day)		4mg
Methotrexate	0 (0%)	0 (0%)
Active Systemic Disease	0 (0%)	0 (0%)
Anti-platelet	10 (50%)	13 (59%)
Statin	12 (60%)	9 (40.9%)
ACE-I/ARB	15 (75%)	11 (50%)
History of Polymyalgia Rheumatica	0 (0%)	7 (31.8%)
History of congenital heart disease	10 (50%)	0 (0%)
Smoking
Current	0 (0%)	6 (27.3%)
Former	7 (35%)	7 (31.8%)

Values are n (%) unless otherwise noted. ESR: Erythrocyte sedimentation time, CRP: C-reactive protein, ACE-I: angiotensin-converting enzyme inhibitor, ARB: angiotensinⅡ receptor blocker.